Podcasts about Wayne State University

July 14, 2025 ~ Paul Kilgore, professor and director of research in the Department of Pharmacy Practice at Wayne State University, talks with Kevin, Lloyd, and Jamie about the United States facing a significant measles outbreak and the low vaccination rates playing a role in this historic 30-year high.

Why is America's Jewish community so successful? Why have Jewish diaspora communities been so successful throughout history and across many countries and cultures?

In this week's episode of Real Integrative Medicine, Dr. Jordan Robertson and Carmen Stansberry discuss the intersection of evidence-based practice and individualized care in women's health. Carmen shares her journey from conventional medicine to a holistic approach, emphasizing the importance of understanding the unique needs of women. They explore the complexities of symptoms like fatigue, the risks of over-screening, and the importance of building trusting relationships in healthcare. The conversation highlights the need for more research in women's health while advocating for a balanced approach that combines evidence with personalized care strategies.----Carmen Stansberry is a double board-certified nurse practitioner specializing in women's hormone health, perimenopause, longevity medicine, and the intersection of hormone deficiency with chronic disease risk and immune dysfunction. She is a leading voice in modern midlife health optimization, advocating for women to take charge of their well-being beyond outdated medical paradigms.As the founder of The Advanced Practice, Carmen not only built a successful private practice but also mentors clinicians on how to launch and scale high-impact, cash-based healthcare businesses that provide specialized and forward-thinking medical care. Through her expertise in clinical strategy, patient-centered care models, and marketing for modernhealthcare, she has helped countless providers transition from traditional systems into thriving, independent practices that prioritize outcomes, prevention, and patient autonomy.Carmen's approach bridges the gap between clinical expertise and business acumen, ensuring that both patients and practitioners have access to next-generation healthcare solutions. Her work has been featured in Verywell Health, Giddy, and multiple podcasts, and she serves as an expert clinical advisor for Hot Flash Inc., a media company dedicated to women's health in midlife.She holds graduate degrees from The George Washington University and Wayne State University and continues to push the conversation forward on women's health, perimenopause, and longevity, ensuring that women receive the evidence-based care they deserve.Learn More on Carmen's WebsiteFollow Carmen on Instagram----Dr. Jordan Robertson is a leader in naturopathic and integrative medicine. She is dedicated to evidence-based healthcare and founded The Confident Clinician, which empowers practitioners with up-to-date research and practical tools. With over 15 years in clinical practice and experience teaching at McMaster University's Health Sciences program, she bridges the gap between research and real-world application.Follow Dr. Jordan on Instagram----Do you ever wish there were a knowledge base built just for you?Have you searched for a resource that supported you so you could focus on what really matters for your business?The Confident Clinician is the ONLY medical knowledge base built for integrative practitioners.Over 750 clinician members have simplified their patient care by using our knowledge base and exclusive members-only education.Our knowledge base and clinical topics are updated on an ongoing basis and, and we offer exclusive members-only courses that support you, whatever your clinical focus.Ready to be supported in your work?Learn More About The Confident Clinician HereDiscover The Confident Clinician's 5-Day AI Smart-Search ChallengeIf you're a clinician and you're loving the content of the show, I'd love to invite you to subscribe to our clinician-focused free magazine called The Stacks. The Stacks offers research focused articles, editorials and opinion pieces on business and practice and unlocks some of our best Confident Clinician content every month.Subscribe to The Stacks Here----Thank you for listening. Please subscribe and share.

July 2, 2025 ~ Dr. Bridget Weller, Social Work Professor at Wayne State University, joins Marie Osborne to discuss the current healthcare worker shortage and WSU's efforts to diversify and grow Michigan's healthcare workforce through The Academy.

Steve Elwell and Joe Lynch discuss avoiding logistics FUD. Steve is the Founder and Managing Director of iDev Partners, a boutique leadership, business strategy and turnaround consulting firm.  Summary: Avoiding Logistics FUD In this episode, Joe Lynch and guest Steve Elwell tackle the pervasive issue of Fear, Uncertainty, and Doubt (FUD) and its impact on various aspects of business, particularly in logistics. Joe and Steve provide valuable insights into overcoming FUD by establishing trust and eliminating disruptive elements within business relationships, and leadership. The conversations delve into strategies for fostering growth, efficiency, and effective sales processes by promoting consistent, reliable behavior and building trustworthy partnerships. They discuss the negative consequences of transactional relationships and emphasize the rewards of creating harmonious environments in team settings, especially against the backdrop of current industrial challenges and transformative periods. With a focus on personal conduct, team bonding, and maintaining customer relationships, this episode serves as a crucial guide for anyone looking to navigate the complexities of fear, uncertainty, and doubt in the professional landscape. #OvercomingFUD #LogisticsLeadership #BuildingTrustInBusiness About Steve Elwell  Steve is the Founder and since 2010 Managing Director of iDev Partners a boutique leadership, business strategy and turnaround consulting firm located in Farmington Hills, MI. In this role he has helps leaders and organizations realize their potential and mission. Steve has lead multiple technology, manufacturing, and start-up businesses as CEO, COO, and President. His consulting clients include large publicly traded corporations and family businesses in industries from logistics to aerospace. Prior to strategy and turnaround, Steve ran an IT, and automation businesses and owned a retained executive search firm. He earned an MBA from Wayne State University in Detroit, and a BA in Economics and Management from Albion College, in Albion, MI. Steve, his wife Kris, and their two children live in Farmington Hill, MI. About iDev iDev serves leaders and businesses in their transition from good to great. We develop clarity and translate that clarity into action and durable sustainable gains. Our approach brings together vision, talent, technology, around realistic solutions, and deliberate high-energy execution. iDev has been successful in diverse situations including turnaround and transformation, crisis management, and strategic growth. iDev leaders have prior consulting experience as well as tenure as C-suite function heads and CEOs. Key Takeaways: Avoiding Logistics FUD Understanding the impact of fear, uncertainty, and doubt (FUD) in logistics and business. Strategies for enhancing business growth, efficiency, and performance by overcoming FUD. The importance of trust, rapport, and leadership in personal relationships. Adapting to industry shifts and challenges by fostering agility and strong partnerships. The risks of transactional relationships and the benefits of transparent, mutually beneficial collaborations. How to counteract the negative effects of FUD by cultivating harmony and effective team dynamics. Timestamps (00:00:02) Avoiding Logistics FUD (00:00:13) Reflecting on FUD in Relationships (00:02:08) Optimizing Business Performance (00:02:57) Impact of Fear and Uncertainty (00:07:52) Navigating Post-COVID Logistics Challenges (00:09:58) Combatting FUD in Sales (00:12:34) The Impact of Sales Conduct (00:18:14) Managing FUD in Business Relationships (00:22:44) Navigating Business Relationships (00:29:22) Transactional Pitfalls in Shipping (00:30:24) Fostering Harmony Over FUD (00:36:02) Building Strong Business Relationships (00:36:27) Leadership and Building Trust (00:41:05) Overcoming FUD in Logistics (00:42:46) Seek Harmony, Avoid Disruption (00:43:26) Identifying Business Pain Points (00:44:30) Wrapping Up Logistics Podcast Learn More About Avoiding Logistics FUD Steve Elwell | Linkedin iDev | Linkedin Supply Chain Disruptions Are Here to Stay with Steve Elwell | The Logistics of Logistics 3 Emerging Supply Chain Trends with Steve Elwell | The Logistics of Logistics Make Heroes, Make Money with Steve Elwell | The Logistics of Logistics Avoiding Fear, Uncertainty, and Doubt in Sales with Steve Elwell | The Logistics of Logistics The Number One Reason Why People Buy with Steve Elwell | The Logistics of Logistics The Only 3 Ways to Improve Your Sales with Steve Elwell | The Logistics of Logistics Understanding the Buying Process with Steve Elwell | The Logistics of Logistics Entering New Logistics Markets with Steve Elwell | The Logistics of Logistics Freight Recession: Opportunity or Threat with Steve Elwell | The Logistics of Logistics The Logistics of Logistics Podcast If you enjoy the podcast, please leave a positive review, subscribe, and share it with your friends and colleagues. The Logistics of Logistics Podcast: Google, Apple, Castbox, Spotify, Stitcher, PlayerFM, Tunein, Podbean, Owltail, Libsyn, Overcast Check out The Logistics of Logistics on Youtube

Horror movies, roller coasters, bungie jumping! Why do we sometimes enjoy the things that scared us?In this episode we chat with Arash Javanbakht, leading psychiatrist & neuroscientist at Wayne State University, who explains to us how fear can be treated and even be used as a motivator.Arash gives us insight into how fear and anxiety can actually work for us, the reasons behind fear, and even tackles the questions of why we sometimes enjoy being frightened. Do you ever wonder why we like to be scared?On today's episode we learn that fear and anxiety are both emotions that are engrained in our genetics going all the way back to the first humans. And for those traumatic experiences where fear gets the best of us, Arash shows us how exposure therapy through augmented reality can be a great form of treatment. Have a question you've been wondering about? Send an email or voice recording to everwonder@californiasciencecenter.org to tell us what you'd like to hear in future episodes.Follow us on Twitter (@casciencecenter), Instagram (@californiasciencecenter), and Facebook (@californiasciencecenter).Support the show

In this episode of Confessions of a Higher Ed Social Media Manager, host Jenny Li Fowler chats with Erica Colaianne, Director of Social Media at the University of Michigan, about the critical art of understanding your audience and staying nimble on social. From building out detailed platform-specific personas to crafting crisis-proof content, Erica shares how her newsroom roots and strategic thinking shape her approach to higher ed communications. If you're looking for real-world strategies for smarter social media management, this is the episode you've been waiting for.Guest Name: Erica Colaianne, Director of Social Media, University of MichiganGuest Social: LinkedInGuest Bio: Erica Colaianne is the Director of Social Media at the University of Michigan where she leads the social communications team that creates dynamic content every day for audiences of more than 2.6 million. Representing a world-class institution known for academic excellence, innovative research, and a vast global alumni network, she strategizes content to continuously educate and engage all audiences. She also drives the coordination of cohesive content strategies for the university, bringing social communicators across U-M together. Through her work cultivating engaged communities and building trust with audiences, she leads strategies that successfully demonstrate the immense impact of the university and encapsulate the Wolverine experience.Erica previously worked in communications and marketing at Wayne State University and prior to joining the higher education community she led communications and marketing efforts for a range of organizations including healthcare, media companies and nonprofits. She graduated from Wayne State University with a bachelor's degree in journalism and received a master's degree in integrated marketing communications from Eastern Michigan University. - - - -Connect With Our Host:Jenny Li Fowlerhttps://www.linkedin.com/in/jennylifowler/https://twitter.com/TheJennyLiAbout The Enrollify Podcast Network:Confessions of a Higher Ed Social Media Manager is a part of the Enrollify Podcast Network. If you like this podcast, chances are you'll like other Enrollify shows too! Enrollify is made possible by Element451 — the next-generation AI student engagement platform helping institutions create meaningful and personalized interactions with students. Learn more at element451.com.Attend the 2025 Engage Summit! The Engage Summit is the premier conference for forward-thinking leaders and practitioners dedicated to exploring the transformative power of AI in education. Explore the strategies and tools to step into the next generation of student engagement, supercharged by AI. You'll leave ready to deliver the most personalized digital engagement experience every step of the way.Register now to secure your spot in Charlotte, NC, on June 24-25, 2025! Early bird registration ends February 1st -- https://engage.element451.com/register

Welcome to the last episode of our 3 part 'Detroit Cares About Caregivers' Series! What resources actually exist for caregivers, and how do you access them when you need support? This question haunts many people thrust into caregiving roles, often leaving them feeling isolated and overwhelmed. In this episode, we bring together powerhouse resources ready to lighten your load—without emptying your wallet.The biggest revelation? Many people providing significant care don't identify as caregivers at all. "If you're providing services for a loved one, a neighbor, anyone that depends on you for assistance, advice, or expertise—you are a caregiver," explains Dr. McNeill, DNP, Project Director of Wayne State University's A.G.R.E.E.D-GWEP program. This critical identity shift opens the door to a wealth of support many never knew existed.We dive deep with experts from three major organizations: Wayne State University's Geriatric Workforce Enhancement Program (a $5 million initiative), the Alzheimer's Association Michigan Chapter, and the Detroit Area Agency on Aging. Each shares concrete resources they offer completely free—from respite care options and support groups to innovative apps that help navigate the healthcare system and ensure accountability from providers.Whether you're new to caregiving or have been shouldering responsibilities for years, this episode connects you with organizations that have already done the hard work of figuring out what caregivers need. As we wrap up our Detroit tour, we leave listeners with practical entry points to engage with these resources—websites, phone numbers, upcoming events, and most importantly, the encouragement to reach out.Remember: Alzheimer's is heavy, but we don't have to be. Follow us for more conversations that bring light to the caregiving journey and subscribe to ensure you never miss an episode that might just change your caregiving experience.For more information about the AGREED program, please visit http://agreed.wayne.edu. Support the show"Alzheimer's is heavy but we ain't gotta be!"IG: https://www.instagram.com/parentingupFB: https://www.facebook.com/parentingupYT: https://www.youtube.com/channel/UCDGFb1t2RC_m1yMnFJ2T4jwPatreon: https://patreon.com/jsmilesstudiosTEXT 'PODCAST" to +1 404 737 1449 - to give J topic ideas, feedback, say hi!Be sure to leave us a review!

In questa puntata torna a trovarci una persona a cui siamo molto affezionati: Silvia Giorgini. Silvia insegna Italiano alla Wayne State University di Detroit, dove tiene un corso affascinante intitolato "La storia, la cultura e la scienza della cucina italiana". Un vero e proprio viaggio attraverso la tradizione gastronomica del nostro Paese, tra qualità, ricerca e identità culturale. Con lei parliamo di cibo – un tema che ci sta particolarmente a cuore – e lo facciamo partendo da un argomento sempre controverso: la pizza con l'ananas. Da lì, per poi passare a Pellegrino Artusi. Parleremo delle radici della cucina italiana e su quanto il cibo sia parte integrante della nostra cultura. Tra una chiacchiera e l'altra, emerge tutta la grandezza e l'importanza del patrimonio culinario italiano. Non perdetevi questa succulenta puntata! Dani & Lia ~~~ In this episode, we are hosting Silvia Giorgini. She teaches Italian at Wayne State University in Detroit, where she offers a fascinating course titled “The History, Culture, and Science of Italian Cuisine.” It's a true journey through Italy's gastronomic traditions, exploring quality, research, and cultural identity. With her, we talk about food – a topic that's especially close to our hearts – starting with a classic, always controversial subject: pineapple on pizza. From there, we move on to Pellegrino Artusi, discussing the roots of Italian cuisine and how deeply food is intertwined with our culture.  

In this episode recorded live from Transact 360, Dustin gets insights from Patrick Beirne who serves as Senior Director of Student Financial Services at Wayne State University. In this rare sit-down with a real-life bursar (finally!), Pat offers a front-line view of how digital transformation is changing the way institutions bill and collect payments—and why it matters more than ever.From phasing out cash to embracing Apple Pay, Pat shares practical insight into building a student-centric (and parent-friendly) payment experience. Plus, he breaks down how integrations, centralization, and modernization are more than IT buzzwords—they're make-or-break moves in the race to remain relevant and responsive in higher ed.Guest Name: Patrick Beirne, Senior Director, Bursar & Student Financial Services, Wayne State UniversityGuest Social: LinkedInGuest Bio: Patrick Beirne has worked in Student Financial Services for 16 years across three university campuses, the last six as the Senior Director; Bursar & Student Financial Services at Wayne State University in Detroit, Michigan.  Patrick has extensive experience utilizing multiple Enterprise Resource Platforms and Integrated Payments solutions.   Patrick is a student centric, retention focused leader, and is most proud of the collaborative partnerships made across campus that have paved the way to creatively recruit, retain, serve, and graduate university students.  Patrick fosters an organizational vision that strives to “retain every student” and “collect every dollar”.  In addition to this student retention and A/R recovery focus, Patrick focuses on data-driven analysis and decision making and the consistent evolution of business process enhancement and efficiency. - - - -Connect With Our Host:Dustin Ramsdellhttps://www.linkedin.com/in/dustinramsdell/About The Enrollify Podcast Network:The Higher Ed Geek is a part of the Enrollify Podcast Network. If you like this podcast, chances are you'll like other Enrollify shows too!Enrollify is made possible by Element451 — the next-generation AI student engagement platform helping institutions create meaningful and personalized interactions with students. Learn more at element451.com.Attend the 2025 Engage Summit! The Engage Summit is the premier conference for forward-thinking leaders and practitioners dedicated to exploring the transformative power of AI in education. Explore the strategies and tools to step into the next generation of student engagement, supercharged by AI. You'll leave ready to deliver the most personalized digital engagement experience every step of the way.Register now to secure your spot in Charlotte, NC, on June 24-25, 2025! Early bird registration ends February 1st -- https://engage.element451.com/register

JCO PO author Dr. Philip Philip at Henry Ford Cancer Institute and Wayne State University shares insights into his JCO PO article, “Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group.” Host Dr. Rafeh Naqash and Dr. Philip discuss how prospective trials are required to clarify the role of ctDNA as a valid surrogate end point for progression-free or overall survival in GI cancers. Transcript Dr. Rafeh Naqash: Hello and welcome to JCO Precision Oncology Conversations, where we bring you engaging conversations with authors of clinically relevant and highly significant JCO PO articles. I'm your host, Dr. Rafeh Naqash, Podcast Editor for JCO Precision Oncology and Assistant Professor at the OU Health Stephenson Cancer Center at the University of Oklahoma. Today, we are excited to be joined by Dr. Philip Philip, Chair of Hematology and Oncology, as well as leader of GI and Neuroendocrine Oncology. He's also the Professor of Oncology and Pharmacology, as well as Co-Leader of the Pancreatic Cancer Program and Medical Director of the Cancer Clinical Trial and Translational Research Office at the Henry Ford Cancer Institute at Wayne State University. Dr. Philip is also the Senior Corresponding Author of the JCO Precision Oncology article entitled, "Incorporating Circulating Tumor DNA Testing into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group." At the time of this recording, our guest's disclosures will be linked in the transcript. Dr. Philip, welcome to our podcast, and thank you so much for joining us today. Dr. Philip Philip: Thank you so much, Dr. Naqash, for providing me this opportunity to be discussing this with you. Dr. Rafeh Naqash: This is a very timely and interesting topic. We've done a couple of podcasts on ctDNA before, but none that is an opinion piece or a guidance piece based on what you guys have done. Could you tell us what led to this perspective piece or guidance manuscript being published? There is some background to this. Could you tell us, for the sake of our listeners, what was the initial thought process of why you all wanted to do this? Dr. Philip Philip: The major reason for this was the fact that investigators were considering using ctDNA as a primary endpoint in clinical trials. Obviously, you hear my focus will be on gastrointestinal cancers. So, the idea was, can we use ctDNA instead of using the traditional endpoints such as disease-free survival, progression-free survival, or overall survival? And the question was, do we have enough data to support that in patients with gastrointestinal cancers? Now, the article obviously goes over some review of the data available, but the core of the article was not to do a comprehensive review of ctDNA use and the evidence so far, although we used that in really putting our recommendations. So, we really had to evaluate available data. But the focus was, what are the gaps? What do we need to do? And are we ready to use ctDNA as a primary endpoint in clinical trials? Dr. Rafeh Naqash: Thank you for giving us that background. Obviously, a very broad, complicated topic with a bunch of emerging data that you've highlighted. But most importantly, for the sake of, again, trainees and listeners, could you help us understand the difference between tumor-informed and non-tumor-based ctDNA assessments? Dr. Philip Philip: Sure. So, the tumor-informed is simply meaning that you're taking the genomic makeup or the DNA fingerprint of the cancer in a given patient, and you create a profile, and then use that profile to see whether that DNA is present in the blood. So, it's very simple. It's like barcoding DNA and then going and looking for it in the blood, which means that you have to have the primary tumor. When I say primary tumor, you need to have the tumor to start off with. It doesn't really apply, maybe easily, if you just have a fine-needle aspirate and things like that. So, you really have to have a good amount of the tumor for you to be able to do that. So, that's a tumor-informed, and from the name, you can easily understand how it's done, compared to the other one, which is uninformed, whereby off-the-shelf probes are used to look for tumor DNA. And again, they're based on prior experience and prior identification of the key DNA changes that will be seen in tumors. So, that's the difference between the two in terms of the principle of the test. The uninformed will not require you to send the original tumor that you're trying to test. However, the informed, you do. The turnaround time is, again, a bit different because, as you would expect, it's shorter in the uninformed. And the reason for that, again, is the initial preparation of the profile that is going to be used in the future when you do serial testing. The sensitivity has been a bit of a discussion. Initially, people have thought that tumor-informed assays are more sensitive, more specific, more sensitive, et cetera. But in our review, we come to the conclusion saying that we don't think that's going to be a major difference. And there are obviously improvements happening in both types of assays. The sensitivities have been improving. So, at this point in time, we do feel that you have two types of assays, and we didn't feel strongly about recommending one over the other. Dr. Rafeh Naqash: Thank you for that description. You mentioned something about sensitivity, specificity. Obviously, many of us who have ordered both tumor-informed and tumor-uninformed, we understand the differences with respect to the timing. The tumor-informed one can take more time. The uninformed one, being a sort of a liquid biopsy, may not necessarily have as much of a turnaround time. Could you briefly speak to those limitations or advantages in the context of the two versions? Dr. Philip Philip: I just really want to also highlight that when we say turnaround time, so for the tumor-informed assays, the first assay that we do will be requiring a turnaround time. But once the pattern has been set and the profile has been documented, the subsequent testing doesn't require much in the way of waiting. However, when you're using this for the minimal residual disease, then you have a window of opportunity to work at. That's number one. So, it means that in patients who have resected cancer, you may end up having to wait longer than the tumor-uninformed assay, especially if you don't have easy access to your material for the baseline material to send. And also, what we'd like to do is not do the test immediately after the operation or soon after the operation. Give it some time. There's a window where you can work at, and starting minimally two weeks after the surgery. But in my experience, I'd like to wait at least four weeks just to make sure that we got an accurate reading. Sometimes when you do it very early after surgery, because of the effect of the surgery and the release of the normal DNA is also, it may dilute the tumor DNA, and then you may get a false negative. So, basically, it depends on the clinical situation. And your question is, is one better to be used than the other? I think ultimately, it ends up with the turnaround time not being as much of an issue. It might be in certain situations, depending on when you see the patients after the operation or any definitive treatment you've done and you want to look for minimal residual disease. But in general, I don't think that's going to be a real major issue. Dr. Rafeh Naqash: I remember discussing this with one of the tumor-informed platforms with regards to this barcode you mentioned. They generate a fingerprint of sorts for the tumor on the tissue, then they map it out in the blood and try to assess it longitudinally. And one of the questions and discussions we had was around the fact that most of the time, these barcoded genes are not the driver genes. If you have a KRAS mutant tumor, it's not going to be the KRAS gene that they map out. It's something that is specific. So, is there a possibility that when you are mapping out, let's say, a metastatic tumor where there is truncal and subclonal mutations at different sites, that you capture something that is not necessarily truncal, and that does not necessarily reflect some other metastatic site having a recurrence? So basically, over time, you don't see a specific mutational pattern or the signature on the tumor-informed, and then you see something on the scan which makes you think, "Well, it was not the right test," but actually it could be a different subclone or a clone mutation at a different site. Is there a concept that could help us understand that better? Dr. Philip Philip: I think you raise a very important point. Although, I have to say from my practical experience, that is not a common thing to see. In fact, for some reason, we don't see it that often in any frequency that should, at this point in time, make us concerned about the serial testing. But what you were mentioning is a real challenge which can happen. Now, the question is, how often does the clonal evolution or the divergence happen to the point that it's going to be like a false negative, is what you're saying. At this point in time, we don't really have good information on that, or any good information, practical information. And when we went through the literature and we were looking for the evidence, that wasn't something which was there clearly telling us. Although, this is something that has to be studied further prospectively. And I don't know of a study, but I might be missing it, I don't know of a study which is systematically looking at this. Although it's a very valid hypothesis and theoretical basis for it, but in real life, we still have to see how much does it really interfere with the validity of this kind of testing. Dr. Rafeh Naqash: Which brings us to the more important discussion around your manuscript. And I think that the overarching theme here is the consensus panel that you guys had recommended that ctDNA-based metrics be used as a co-primary endpoint. Could you tell us, for early-phase trials, maybe phase two studies for that matter, could you tell us what were some of the aspects that led to this consensus being formed from your working group? Dr. Philip Philip: Well, there were a number of reasons, in any order of priority, but one of them is we don't have a good sense of dynamics of the ctDNA. And again, remember this article was about gastrointestinal cancers. Maybe we know more about colon cancer, but, or colorectal cancer, but we don't know that well about the upper GI, like gastroesophageal, pancreatic, et cetera. So, we don't know what is the false negative percentages. And in fact, we know that there are certain sites of the disease, metastases, that do not lead to enough shedding of the DNA into the circulation. So, that was something else. I mean, false negativity, not knowing exactly what the dynamics are, especially in different disease types. So, that was another reason, which we felt that it may not be at this time primetime to really have those ctDNA tests as a primary endpoint. We wanted to make sure that, on the other hand, we wanted to make sure that people consider including ctDNA more like a secondary endpoint so that we can gain the information that we're lacking, at least the ones I mentioned to you. So, that was an important point of our discussions and deliberations when we were writing the article. Dr. Rafeh Naqash: And I myself have been on both sides of the aisle where - I treat people with lung cancer, you mentioned appropriately that most of the data that we have for ctDNA is generated from GI cancers, especially colorectal - on the lung cancer side, I myself had a patient with an early-stage cancer, had treatment, surgery, immunotherapy, and then had ctDNA that was tumor-informed, was positive four to five months before the imaging actually showed up. And on the other side, I've also had an individual where early-stage lung cancer, surgery, immunotherapy, and then had PET scans that showed a positive finding, but the ctDNA, tumor-informed ctDNA, was negative multiple times. So, I've seen both aspects of it, and your paper tries to address some of these questions on how to approach a negative, radiologically negative imaging but positive ctDNA potentially, and vice versa. Could you elaborate upon that a little bit? Dr. Philip Philip: Well, obviously, we do see this in practice. Again, I do GI oncology. I have patients who, you do ctDNA. I mean, my advice to anyone, when you order a test, you have to make sure that you know what you're going to do with the test, because that's the most important thing. You get a positive test, you do something. You get a negative test, you do something. But most importantly, our patients who you're following up, they are very anxious for a diagnosis they have that is not- I mean, it's cancer. If you're doing these tests, if we get continuous, repeatedly negative testing, then you really have to also tell the patient that there's a false negativity. And I mentioned to you earlier, there are certain sites of disease, like peritoneal, they may not be producing enough, or there are some tumors, their biology is such that they don't release as much to be detected in the blood. Now, one day we will get maybe a more sensitive test, but I'm talking about the tests we have now. On the other hand, if you get a positive testing, you have to make a distinction for ctDNA in the minimal residual disease situation. If you get a positive test, there is enough evidence that the patient has a worse prognosis. There's evidence for that. No one can dispute that. Again, I'm talking about colorectal cancer where there are a lot of data for that. So, in that situation, there are studies that are looking, if you get a positive test in someone who you're not intending to give any adjuvant treatment, there are studies looking into that, both in terms of intensifying, like chemotherapy, in certain patients. And also, there's work being done, if you have a negative test in someone who has stage III disease, for example, or definitely stage II disease, they may not need to give them chemo. Those things are happening. But in metastatic disease, it's a different situation. Or even in someone who has received surgery, adjuvant chemotherapy, in those patients where they, whether they're now under, in the surveillance mode, those patients, if you have a positive, it may be positive. I had a recent patient like those, eight months before we saw anything on the scans. So, the question is, if you have a positive test, is there any advantage in giving them treatment, systemic treatment? Of course, we're assuming that the PET scan is negative. So, is there really any advantage in giving someone treatment ahead of time, before you see the imaging changes? That kind of data, in my opinion, is not really available or strong. You can always think of it in different ways, explain it in different ways. It's minimal disease, maybe you get a better response. But I don't know if we really can justify at this time. Therefore, in my practice, my own practice, I do not treat just a positive ctDNA. Again, that's different than after surgery when you're thinking of whether to give adjuvant treatment, no adjuvant treatment. But someone who's finished treatments and then you're just serially monitoring the disease, those patients, I do not treat them with chemotherapy. And that was something which, based on the literature we reviewed, there was nothing out there to definitely- I mean, if you see something positive, you will do a scan earlier, you will talk to the patient, examine the patient, whatever. But if there's nothing there, starting a treatment, that's not justified at this point in time. Now, you need to do a study like that. Definitely, you need to do a study. But I can tell you that from my experience, having been involved with study design and all that, it's not an easy trial to do. It's going to be a trial- at a minimum, it will take many patients, it will take longer time to complete, and there are a number of variables there. If someone is willing to put a lot of money into it, it can be done. But I can tell you that that kind of intention to do a study like that has been very much a challenge at this time. Dr. Rafeh Naqash: Of course, as you mentioned, the follow-up time that you need for a study like that is going to be very long to get to meaningful outcomes. Dr. Philip Philip: You need to be very patient to do such a study. But the problem with a very long study is that things change, standard of care changes with time, and the assays will change. So, that's why we don't have that kind of data. I'm not sure if there are people in the community or in the academic centers who do treat based on only positive ctDNA. The other thing is that you really have to always consider the psychological impact of these tests on patients and caregivers. Sometimes it can be really very stressful, burdensome to people to sit there just waiting for the disease to show up on a scan. And therefore, in my opinion, I'm not saying definitely don't use it in that situation, I'm just saying that you have to personalize it also, to see the patient who you would like to do it and then other patients who may not do it, or you think that it's not good for them to do it. And the patient also has to understand the outcome of the test and how you're going to be interpreting it. Dr. Rafeh Naqash: That's a lot of great insights, Dr. Philip, and I know you've been involved in trial designs. I'm sure NCT and cooperative groups are actively thinking and incorporating ctDNA-based metrics as one of the endpoints in their trial. I know of a GU study that's, I think it's an Alliance study, trying to de-escalate treatment based on ctDNA. I have one of my colleagues who's also a GU investigator at OU, he's doing a ctDNA-based, tumor-informed-based de-escalation. So, obviously, more and more data, hopefully, that'll be generated in the next couple of years. Dr. Philip Philip: But remember, these studies are not using it as an endpoint. They're using it as a means of optimizing treatment, which is a bit different. So, as an endpoint, can you do a phase III trial of, let's say, a thousand patients, and your primary endpoint is not survival, but you're saying, "Can I reduce the ctDNA, clear it earlier, or whatever?" That's the sort of thing this article was about. We can't do that at this time. Dr. Rafeh Naqash: I totally understand. Thank you for explaining the difference, and hopefully more to come in this space in the next couple of years. I briefly wanted to touch upon your personal career and journey based on all that you've done and accomplished. Could you tell us about how you started, what your journey has been like, and how that connects with what you're doing right now, including mentoring other trainees and junior faculty? Dr. Philip Philip: Well, when I was in high school, I wanted to be an engineer, but I grew up in Baghdad, and all my friends wanted to do medicine, so I went with the tide, so I did medicine. I don't regret that. I would do it again if I had the opportunity. The reason why I did oncology was, I left the country and did a PhD in clinical pharmacology at the University of London. And that really got me, it was a topic which included, which was on cancer. So, I really got interested in a disease that is really a lot of science, and things are new, or were new at the time. And if I want to look back what I was doing, the beginning of my training in the 80s, second half of the 80s, and now, it's unbelievable how things have changed. But one of the things which I really have to say is that almost all my life I've been in what we call academic institutions. But I firmly believe that for people, whether academic or not, you have to be a very good, astute clinician, because many of the things we do, really, we're trying to put the patients in the center. It's not only doing fancy science, it's to do things that help the patients. And you can bring in bits and pieces of fancy science or less fancy science, but that's something which is really extremely important for us to think about, being a very good clinician, very good doctor, because medicine is a science, whether you're practicing as a solo practitioner or you're part of a large academic center. It's the way you think, the way you interrogate things that you're not sure of, the way you collaborate, the way you learn every day. I mean, at my age, I still don't like to miss any tumor board, because in each tumor board, there's something you learn, even if you think that you know everything. So, that's really the whole thing of it, is that be a very good clinician, be open-minded. Always, you have to think of things that, they look interesting, they look somehow unexplained. Always try to help find the solutions and do that. One of the major things that I feel that people should do is being also very focused on things. I mean, you have to also know what you want to do in the next 5, 10, 15 years. Because although everyone is in it in the same way when we start, but there are different things that drive people, people who want to do more of the formal research, like being an academic-like institution. But there are also a lot of people who are very successful outside of a- what we call an academic setting. In the United States, most people are not working in an academic kind of setting. Although, for me, the distinction between academic and community is getting less and less, because if you think that you do phase I trials in academia only, that's not true, because there are, in fact, in the state of Michigan, the most active phase I doctor is not even in academia, he's in private practice. So, you can do all these things. It's a matter of what you like to do, and you really have to make sure you know what you want to do. Because sometimes people are, especially early on, they get a bit confused, “What I want to do.” There's an issue of doing general oncology versus subspecialist. If you're a subspecialist doing only GI, you have to make sure that you really also have some kind of recognition that you're only a GI oncologist, recognition regional, national, international, but some degree of recognition that you feel that people are coming to you for advice as a second opinion or whatever it is. But again, you have to decide what you think you want to be, how you want to be, because there's a lot of options here between community practice, academic practice, industry, and of course, there's always the administrative thing. Some people tend to be more like going into the line of being an administrator. So, there's a lot of options for you. Dr. Rafeh Naqash: Well, thank you again, Dr. Philip, for those pearls of wisdom. I think that was very insightful. I'm sure all the trainees and early-career investigators will find all that advice very helpful. Thank you again for joining us today. Thank you for listening to JCO Precision Oncology Conversations. Don't forget to give us a rating or review, and be sure to subscribe so you never miss an episode. You can find all ASCO shows at asco.org/podcast. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Dr. Philip Philip Disclosures Honoraria: Bayer, Ipsen, incyte, Taiho Pharmaceutical, Astellas Pharma, BioNTech SE, Novocure, TriSalus Life Sciences, SERVIER, Seagen Consulting or Advisory Role: Celgene, Ipsen, Merck, TriSalus Life Sciences, Daiichi Sankyo, SynCoreBio, Taiho Pharmaceutical Speakers' Bureau: Incyte Research Funding: Bayer (Inst), incyte (Inst), Merck (Inst), Taiho Pharmaceutical (Inst), novartis (Inst), Regeneron (Inst), Genentech (Inst), halozyme (Inst), Lilly (Inst), Taiho Pharmaceutical (Inst), merus (Inst), BioNTech SE (Inst) Uncompensated Relationships: Rafael Pharmaceuticals, Caris MPI  

In this episode, I sit down with Dr. David Klurfeld—longtime USDA scientist and one of the few insiders to publicly challenge the WHO's classification of red meat as a carcinogen. We go deep into the flawed evidence behind the infamous 2015 IARC report, why nutritional epidemiology often fails to prove causality, and how a small group of researchers helped shape global policy with low-quality science. If you've ever felt confused about meat, saturated fat, or dietary guidelines, this conversation will help you think critically about what “counts” as evidence—and who gets to decide. We cover:Dr. Klurfeld's personal journey and lessons from a career in public healthWhy the 2015 IARC red meat classification was based on weak and inconsistent evidenceHow observational studies and “allegiance bias” mislead nutrition scienceThe politics of dietary guidelines and the role of the USDA and WHOWhat the media got wrong—and why red meat remains a nutrient-dense foodWhether you're a clinician, dietitian, or simply trying to make better nutrition decisions, this episode is a powerful reminder that bias, groupthink and weak data can distort science and mislead the public. We need to be discerning about the nutrition and health advice we follow. Who is Dr. David Klurfeld?Dr. David Klurfeld is a nutritional scientist and former National Program Leader for Human Nutrition at the USDA's Agricultural Research Service. He also served as Professor and Chair of Nutrition and Food Science at Wayne State University and Associate Editor of The American Journal of Clinical Nutrition. He has authored more than 200 scientific publications and was one of 22 experts invited to the 2015 IARC working group on red meat and cancer. He is a longtime advocate for scientific integrity in public health policy.This episode is brought to you by: LMNT- Free Sample Pack with any purchase, visit https://DrinkLMNT.com/DRLYONTimeline - Get 20% off your order of Mitopure - https://timeline.com/LYONMUDWTR - Use code DRLYON to get up to 43% off your starter kit - https://mudwtr.com/DRLYONNeeded - Use code DRLYON for 20% off your first order - https://thisisneeded.com Find Dr. David Klurfeld at: Indiana University Bloomington - https://publichealth.indiana.edu/about/directory/David-Klurfeld-dmklurfe.html Google Scholar - https://scholar.google.ca/citations?user=Ym5Og20AAAAJ&hl=en LinkedIn - https://www.linkedin.com/in/david-klurfeld-812845209/ Find me at:Instagram:@drgabriellelyon TikTok: @drgabriellelyonFacebook: facebook.com/doctorgabriellelyonYouTube:

June 17, 2025 ~ Wayne State University professors Saeed Khan and Howard Lupovitch talk with Chris, Lloyd, and Jamie about the escalating conflicts in Israel and Iran.

June 17, 2025 ~ Wayne State University professors Saeed Khan and Howard Lupovitch talk with Chris, Lloyd, and Jamie about the escalating conflicts in Israel and Iran.

June 16, 2025 ~ Jim Townsend, Director of Levin Center at Wayne State University Law School, joins Dave Trott to share the work of the law center and its new book, Congress Investigates.

In this episode of Liver Lineup: Updates & Unfiltered Insights, hosts Kimberly Brown, MD, a professor of Medicine at Michigan State University and Wayne State University, associate medical director of the Henry Ford Hospital Transplant Institute, and medical director of Transplant Outreach Services at Henry Ford Hospital, and Nancy Reau, MD, a professor of internal medicine, the Richard B. Capps Chair of Hepatology, associate director of solid organ transplantation, and the section chief of hepatology at Rush University Medical Center, highlight 4 key abstracts presented at the 2025 European Association for the Study of the Liver (EASL) Congress. Key Episode Timestamps 00:00:01 Introduction 00:00:45 Efimosfermin Alfa in MASH 00:05:56 PEth Testing 00:13:19 RETRACT-B 00:20:44 Linerixibat in PBC Relevant Disclosures for Reau include AbbVie, Gilead, Salix, Arbutus, and VIR. Relevant disclosures for Brown include Mallinckrodt Pharmaceuticals, Gilead, Salix, Intercept, Ipsen, and Madrigal.

In this episode of Liver Lineup: Updates & Unfiltered Insights, hosts Kimberly Brown, MD, a professor of Medicine at Michigan State University and Wayne State University, associate medical director of the Henry Ford Hospital Transplant Institute, and medical director of Transplant Outreach Services at Henry Ford Hospital, and Nancy Reau, MD, a professor of internal medicine, the Richard B. Capps Chair of Hepatology, associate director of solid organ transplantation, and the section chief of hepatology at Rush University Medical Center, continue their discussion on notable abstracts presented at the 2025 European Association for the Study of the Liver (EASL) Congress. If you haven't already, be sure to check out part 1 here! Key Episode Timestamps 0:00:00 LITMUS Study 0:05:47 Norursodeoxycholic Acid in PSC 0:10:12 GLOBE Score for PBC 0:15:11 Conclusion Arbutus, and VIR. Relevant disclosures for Brown include Mallinckrodt Pharmaceuticals, Gilead, Salix, Intercept, Ipsen, and Madrigal.

Parenting Up family, we are excited to bring you a new 3-part series in partnership with Wayne State University's AGReed grant! In this episode, Detroit caregivers speak with J Smiles about their experiences as caregivers for their loved ones with dementia. They discuss the physical demands, logistics, and emotional stress while also offering self-care strategies to prevent burnout.As always, caregivers also spoke about funny moments with their loved ones that provide levity during the tough times of dealing with this horrible disease. To learn more about Wayne State's AGReed Grant - visit agreed.wayne.edu! Host: J SmilesProducer: Mia Hall editor: Annelise UdoyeVideo and Studio: Evry Media DetroitSupport the show"Alzheimer's is heavy but we ain't gotta be!"IG: https://www.instagram.com/parentingupFB: https://www.facebook.com/parentingupYT: https://www.youtube.com/channel/UCDGFb1t2RC_m1yMnFJ2T4jwPatreon: https://patreon.com/jsmilesstudiosTEXT 'PODCAST" to +1 404 737 1449 - to give J topic ideas, feedback, say hi!Be sure to leave us a review!

Join "Dance Talk” ® with Joanne Carey and special guest Anna SperberIn this episode of  "Dance Talk” ® , host Joanne Carey interviews choreographer Anna Sperber, who shares her journey into the world of dance, her education, and her artistic identity. They discuss her upcoming piece 'Beacons' at the American Dance Festival, the role of the audience in dance, and the creative process behind choreography. Sperber reflects on the influence of motherhood and Martha Graham on her work, the importance of somatics, and her initiative 'Class, Class, Class' aimed at fostering new teaching talent. The conversation culminates in her thoughts on receiving the Bessie Award and her excitement about returning to ADF.Anna Sperber is a Brooklyn-based choreographer and performer. Her work has been described by The New York Times as “immediately compelling” and “wonderfully strange” with “moments of theatrical magic.” Her performances are rooted in the poetic potency of choreography and its potential for perceptual transformation, embodying a tension between formality and chaotic wildness.Sperber received a 2022 New York Dance and Performance “Bessie” award for Outstanding Choreographer / Creator for Bow Echo (2021). Her work has been presented and commissioned by The Kitchen, The Joyce Theater UNLEASHED Series, The Chocolate Factory, Baryshnikov Arts Center, Roulette, Gibney Dance, and Dance Theater Workshop in New York City, as well as by the American Dance Festival in Durham, NC. Sperber has received fellowships and residencies at MacDowell, Yaddo, Bogliasco Foundation in Bogliasco Italy, the Marble House Project, as a Schonberg Fellow at Dance The Yard, Dance Initiative in Carbondale Colorado, Center for Performance Research, Gibney Dance DiP (Dance in Process), Brooklyn Arts Exchange, Lower Manhattan Cultural Council, and Movement Research. Her work has been supported by New Music USA Live Music for Dance, Mertz Gilmore Foundation, The Jerome Foundation, and Brooklyn Arts Council, Cafe Royal Cultural Foundation, and a 2025 NYSCA Grant to Individual Artists. Sperber has collaborated extensively with esteemed experimental composers and live musicians as well as visual designers in New York City. These interdisciplinary collaborations are crucial to the integration of visual and sonic landscapes with the moving body in her work. As a performer, she has worked with many New York-based choreographers including luciana achugar and Juliette Mapp.Sperber was a co-founder of classclassclass, designed to nurture new dance teachers while offering reduced class rates, and has taught as a guest artist at American Dance Festival, Movement Research, Freeskewl, Gibney Dance, Hunter College, George Washington University, and Wayne State University. Sperber founded and ran BRAZIL, a studio and intimate performance space in Bushwick, Brooklyn from 2004 to 2014 and Sunset Space from 2019-2020. More about Annahttps://www.annasperber.com/See the performance at American Dance Festivalhttps://americandancefestival.org/event/anna-sperber/2025-06-25/“Dance Talk” ® with Joanne Careywherever you listen to your podcasts. ⁠⁠⁠⁠⁠⁠https://dancetalkwithjoannecarey.com/⁠⁠Follow Joanne on Instagram @westfieldschoolofdance Tune in. Follow. Like us. And Share. Please leave a review! “Dance Talk” ® with Joanne Carey "Where the Dance World Connects, the Conversations Inspire, and Where We Are Keeping Them Real."

Curious what IDS can do for you? We're glad you asked. This week, we're joined by Dr. Steve Daveluy as he walks us through how what he's learned at the Integrative Dermatology Symposium has changed the way he treats patients and the way he lives his own life. Listen in as he discusses biodiversity in diet, eating healthy foods on a budget, and why you might want to reconsider that glass of milk. Each Thursday, join Dr. Raja and Dr. Hadar, board-certified dermatologists, as they share the latest evidence-based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com.   Catch Dr. Daveluy live at IDS2025 for more on psoriasis in dermatology!   Steven Daveluy, MD FAAD  is a professor and program director at Wayne State University in Detroit, Michigan. He earned a bachelor's in science from Michigan State University. He completed medical school and his dermatology residency at Wayne State University. He holds special interests in teledermatology, noninvasive skin imaging, skin of color, integrative dermatology, and complex medical dermatology, including hidradenitis suppurativa.  

Tech Town Announces Launch of New Program - Live, Innovate, Play program. Workshops kick off this summer through Wayne State University.

Host Polly Swingle welcomes Dr. David Gordon, MD, Dr. Jarhed Macarubbo Peña, PhD, LPC, CRC, Dr. Mary McLaughlin, PT, DPT, and Corinne DiPrima, MS, OTRL, to talk about their involvement in the multidisciplinary Chronic Pain Mangement Program of Michigan. If you experience chronic pain, treat patients with chronic pain, or know someone with chronic pain, this episode holds a ton of excellent information to help those individuals.Dr. David Gordon, MD, is a Physiatrist in practice for 28 years with RPPC, a private practice in Southeastern Michigan in operation for 58 years and having trained hundreds of Physiatrists including himself over the years. Prior to graduating from Residency under RPPC at Sinai Hospital in Detroit in 1997, he graduated Medical school from Wayne State University school of Medicine in 1993. As part of his training and later clinical practice, he had the opportunity of working with the pre eminent chronic pain program, "The Functional Recovery Program of Michigan" during it's 20 year tenure under the direction of my mentor Dr. Maury Ellenberg, MD. As a result of his experience coupled to the developing Opioid Crisis of the late 1990's, he developed a keen interest in providing effective chronic pain management without the use/misuse paradigm implicit with the opiate crisis. With this as motivation, he wrote the ebook "Debunking Chronic Pain Management Misconceptions and finally finding practical solutions published in 2009.Dr. Jarhed Macarubbo Peña, PhD, LPC, CRC specializes in psychophysiological approaches to complex health conditions. He integrates evidence-based modalities from somatic therapy, mindfulness, biofeedback, and Acceptance and Commitment Therapy (ACT). Dr. Peña completed his studies at Michigan State University with a focus on stress responses in autistic young adults. He previously worked as a clinical therapist in a private practice and had served in academic and research roles at Michigan State, contributing to peer-reviewed publications on autism, vocational rehabilitation, and rural health equity. He has an independent practice helping patients with various autonomic nervous system dysfunction including chronic pain, functional neurological disorders, pelvic floor dysfunction, irritable bowel syndrome (IBS), tinnitus, hypertension, POTS, fibromyalgia, and anxiety disorders. Dr. Peña brings a background in exercise physiology and over a decade of interdisciplinary experience in rehabilitation, behavioral health, and wellness.Mary McLaughlin, PT, DPT is a doctor of physical therapy at The Recovery Project- Livonia. She is passionate in treating patients with chronic pain and has been a leader in the development of the Chronic Pain Management Program of Michigan. She developed her skills with tying in physical function with neurological disorders at the Lansing Recovery Project where she was a treating therapist for FND in the LIFE program, restoring individuals with functional movement disorders to healthy movement patterns.Corinne, MS, OTRL, is an occupational therapist with over 10 years of experience, including nearly eight years at The Recovery Project. She specializes in pelvic health, functional neurological disorders, and chronic pain. Corinne is passionate about treating the whole person, integrating evidence-based practice with a compassionate, trauma-informed approach. She is dedicated to helping clients regain autonomy and improve quality of life through personalized, goal-oriented interventions.Learn more about The Recovery Project! View our website at www.therecoveryproject.net Call us 855-877-1944 to become a patient Follow us on Instagram Like us on Facebook Thanks for listening!

In this episode, I'm thrilled to welcome back Dr. Aaron Boster, he is a board-certified Neurologist specializing in Multiple Sclerosis and related CNS inflammatory disorders. Dr. Boster joins me to share his powerful ‘5 for 5' framework—five essential strategies to slow MS progression and improve your quality of life with multiple sclerosis. We break down each pillar: smoking cessation, exercise, nutrition, mindfulness, and choosing the most effective disease-modifying therapy. Dr. Boster offers practical advice that's easy to understand and apply, covering everything from hydration tips and vitamin D to how to make exercise a sustainable part of your MS lifestyle. If you're looking for expert MS management strategies, actionable exercises, and ways to support your MS journey, you won't want to miss this empowering conversation! Tune in for clear, actionable tips to take control of your MS and live your best life. About Dr. Aaron Boster: Aaron L Boster, MD, is a board-certified clinical neuroimmunologist specializing in Multiple Sclerosis. As a neuroimmunologist, Dr Boster provides diagnosis and treatment for all types of MS as well as a wide range of neuroimmunological conditions. He also provides medical management of refractory severe spasticity with expertise in intrathecal baclofen. Dr. Boster received his undergraduate degree from Oberlin College in Oberlin, Ohio and his medical degree from the University of Cincinnati College of Medicine in Cincinnati, Ohio. Dr Boster completed his internship and neurology residency through the University of Michigan in Ann Arbor, Michigan. He continued his training at Wayne State University in Detroit, Michigan, where he completed a fellowship focused on clinical neuroimmunology and multiple sclerosis. He has over a decade and a half of experience combating MS in the clinic and participating in MS clinical research. Connect with Dr. Aaron Boster: Twitter: https://twitter.com/aaronbostermd Youtube: https://www.youtube.com/c/AaronBosterMD Facebook: https://www.facebook.com/AaronBosterMD/ Website: https://bosterms.com/ Additional Resources: https://www.doctorgretchenhawley.com/insider Reach out to Me: hello@doctorgretchenhawley.com Website: www.MSingLink.com Social: ★ Facebook: https://www.facebook.com/groups/mswellness ★ Instagram: https://www.instagram.com/doctor.gretchen ★ YouTube: https://www.youtube.com/c/doctorgretchenhawley?sub_confirmation=1 → Game Changers Course: https://www.doctorgretchenhawley.com/GameChangersCourse → Total Core Program: https://www.doctorgretchenhawley.com/TotalCoreProgram → The MSing Link: https://www.doctorgretchenhawley.com/TheMSingLink

This week, Donna and Orlando sat down with Jonathan Barlow to discuss his vision for Detroit's future. This episode is the sixth in a series of interviews with candidates in the race to become Detroit's 76th mayor.Jonathan Barlow is a Detroit Public Schools graduate, attendee of Wayne State University, CEO, and lifelong advocate for youth, families, and entrepreneurs. He has spent over 20 years fighting for Detroit's future, helping homeowners during the foreclosure crisis, building businesses that create jobs, and working with city leaders to drive economic growth.Jonathan is running for mayor because he believes Detroit deserves leadership that works for all of us - not just the few. His vision is to bring good-paying jobs, affordable housing, modernized city services, and innovative technology solutions that will propel Detroit forward.To learn more about Jonathan Barlow and his vision for Detroit, click here.Support the showFollow us on Instagram, Facebook and Twitter.

Drs. Jensen and Richey welcome Dr. Nicole Brouyette to Dean's Chat! Dr. Brouyette currently serves as the Associate Program director for Henry Ford Health System Residency program in Detroit MI. She got her undergraduate degree at Wayne State University with a Bachelors of Science in Molecular biology. She completed her Doctorate of Podiatric Medicine with the Ohio College and completed her 3 yr surgical residency training program with St. Johns Hospital and Medical center in Detroit MI. Join us as we discuss “all things podiatric medicine and surgery!”  This episode is sponsored by Bako Diagnostics! Dr. Brouyette is a true leader in the profession. Tune in for our discussion about her role as Associate program director and the overall structure and flow of the Henry Ford Health System Residency program. She also leans in and shares her experiences starting the Paragon28 Women in Podiatric Surgery Summit. Dr. Brouyette discusses the importance of female mentorship and some of the barriers young women face in medicine as they try to juggle the various roles they wish to pursue. She speaks openly and honestly about the challenges of being a woman in healthcare and how sometimes our own expectations can add additional stress in our lives. The discussion is uplifting, vulnerable and authentic as we discuss residency training, motherhood, maternity leave, feeling the need to fit into group and the power and freedom of living an authentic life.   Her career has been built on excellence. She has served in numersou leadership roles including ACFAS Great Lakes region Vice President, Member of the ACFAS Education and Scientific affairs committee, and faculty for AO NOrth America. She serves as section editor for the Journal of Foot and Ankle Surgery, NBPME Joint review panel for practitioners Part1 and has published a myriad of journal articles, poster presentations and invited lectures to various educational symposiums. We hope you enjoy this episode!    https://bmef.org/  https://paragon28meded.com/weekend-dpm-2024/vital-voices-womens-summit  https://www.abfas.org/residents  https://www.acfas.org/  https://www.aofoundation.org/aona     

The contest is intended to pick the most promising new brick and mortar business concept. The businesses competing in this competition are doing so to win a hundred thousand dollars from Comerica Bank to take their concept to reality and actually open a physical store in either Detroit, Hamtramck, or Highland Park. 10 small businesses are competing as semi-finalists and the public will vote on their favorite until May 23rd. Go to hatchdetroit.com to have your voice be a factor in this.

This episode is sponsored by Lockton, click here to learn more Season Five of the Automotive Leaders Podcast comes to a close, and with it, a year of powerful conversations that challenged the way we think about leadership in the automotive industry.This season wasn't just about bringing guests to the mic—it was about tackling real-world issues. From supplier risk and global tariffs to leadership challenges inside some of the industry's biggest names, every episode added a new layer to understanding where the automotive world is headed.Jan also took the podcast further than ever before, introducing translated episodes in Spanish and Ukrainian to reach a broader, more diverse audience. Live recordings from the Detroit Auto Show and the MEMA Annual Conference added fresh perspectives straight from the heart of the industry.We even ventured into academia, with conversations featuring the president of Kettering University and students from Wayne State University, offering a glimpse into the future of the workforce.With Season Six already in motion and a major episode on the Working Relations Index dropping on May 22nd, the journey continues. And if this season proved anything, it's that authentic leadership starts with honest conversations—and those are far from over.Themes discussed in this episode:The growing need for authentic leadership in the automotive industrySupplier risk and resilience in a challenging global marketThe impact of tariffs on suppliers and trade dynamicsHow OEM-supplier relationships shape the future of the industryInsights from academia on preparing the next generation of industry leadersHow emerging platforms like TikTok are influencing the industry narrative.Leadership lessons shared by top executives across the automotive sectorWhat to expect from the upcoming Working Relations Index dataYour HostJan Griffiths is the architect of cultural change in the automotive industry. As the President & Founder of Gravitas Detroit, Jan brings a wealth of expertise and a passion for transforming company cultures. Additionally, she is the host of the Automotive Leaders Podcast, where she shares insightful conversations with industry visionaries. Jan is also the author of AutoCulture 2.0, a groundbreaking book that challenges the traditional leadership model prevalent in the automotive world. With her extensive experience and commitment to fostering positive change, Jan is at the forefront of revolutionizing the automotive landscape. Reach out to her at Jan@gravitasdetroit.comMentioned in this episode:The Gap and The Gain: The High Achievers' Guide to Happiness, Confidence, and SuccessWhy Automotive Leaders Need Emotional Intelligence with Daniel Goleman

On this week's episode of The 1 Girl Revolution Podcast, we welcome Tayler Jones — actress, director, teaching artist with Detroit Creativity Project, and founder of Detroit Beauty Box. Tayler is a proud product of Detroit Public Schools, a multi-talented theatre artist, and a passionate advocate for the power of art and creativity—especially in the lives of young people. She received her BFA in Acting from Wayne State University, her MFA in Applied Drama from Eastern Michigan University, and studied Advanced Actor Training at the Moscow Art Theatre School. Tayler's impressive career spans stage, screen, and the classroom, but her greatest work may be the impact she's having on the next generation. Through her work with Matrix Theatre Company and the Detroit Creativity Project, Tayler teaches improv and life skills to youth in Detroit—using theatre as a powerful tool to build confidence, resilience, and connection. In this episode, you'll hear: ➡️ Tayler's journey from childhood performer to professional actress and educator ➡️ How the Detroit Creativity Project is transforming young lives through improv and creativity ➡️ The story behind Beauty of Detroit Box and how it builds community and supports local businesses ➡️ A heartfelt conversation on miscarriage and infant loss, and how Tayler is honoring her baby's legacy ➡️ More about the amazing organization Remembering Cherubs and their mission to support grieving parents ➡️ Why art, music, theatre, and creativity matter now more than ever ➡️ And so much more!

May 14, 2025 ~ Trump's first international trip in his second term focuses on the Middle East, including stops in Saudi Arabia, Qatar, Turkey, and Syria, with the goal of rewriting U.S. strategy in the region. Saeed Kahn, associate professor of Teaching in Near Eastern Studies at Wayne State University, discusses how this approach differs from recent administrations.

Felicia B. George is a native Detroiter who loves Detroit history and culture. She earned her doctorate in anthropology from Wayne State University, where she is now an adjunct professor. Her recent book, When Detroit Played the Numbers: Gambling's History and Cultural Impact on the Motor City, was released by Wayne State University Press in 2024 and has been named as a 2025 Michigan Notable Book by the Library of Michigan.www.doctordetroit.nethttps://wsupress.wayne.edu/9780814350768/

ORIGINALLY RELEASED Mar 10, 2023 In this episode of Guerrilla History, we bring on two fantastic guests, Prof. Charisse Burden-Stelly and Prof. Jodi Dean. We discuss their co-edited collection, Organize, Fight, Win: Black Communist Women's Political Writing, which is an absolutely indispensable resource for those of us serious about achieving liberation!  This collection includes writings focused on the period from 1919-1956, which argue that racial and economic equality can only be achieved by overthrowing capitalism.  Pick up the book! Dr. CBS is an Associate Professor of African American Studies at Wayne State University.  She is an organizer with Black Alliance for Peace and a Co-Author of W.E.B. Du Bois: A Life in American History alongside our mutual friend Gerald Horne.  She can be followed on twitter @blackleftaf or on her website https://www.charisseburdenstelly.com/. Dr. Jodi Dean is a Professor of Political Science at Hobart and William Smith Colleges.  She is the author of numerous books including Comrade: An Essay on Political Belonging, Crowds and Party, and The Communist Horizon.  She can be followed on twitter @jodi7768. ---------------------------------------------------- Support Rev Left and get access to bonus episodes: www.patreon.com/revleftradio Make a one-time donation to Rev Left at BuyMeACoffee.com/revleftradio Follow, Subscribe, & Learn more about Rev Left Radio HERE

Today's podcast features Stephen Calkins, a law professor at Wayne State University in Detroit and former General Counsel of the Federal Trade Commission (the “FTC”). President Trump recently fired, without good cause, the two Democratic members of the FTC, leaving only two Republican members as commissioners. He did this even though the FTC Act provides that a commissioner may be fired by the President only for good cause and that the commission is to be governed by a bi-partisan 5-member commission This is the third time in the past few weeks that Trump has fired without good cause democratic members of other federal agencies; the other two being the National Labor Relations Board (The “NLRB”) and the Merit Selection Protection Board (The “MSPB”). The statutes governing those two agencies, like the FTC Act, allow the President to fire a member of the governing board for good cause only. The fired members of all three agencies initiated lawsuits in federal district court for the District of Columbia, seeking mandatory preliminary injunctions requiring those agencies to reinstate them with back pay. We discuss the status of the two lawsuits and how the outcome will turn on whether the Supreme Court will apply or overrule a 1935 Supreme Court opinion in Humphrey's Executor, which held that the provision in the Constitution allowing the President to fire an FTC commissioner for good cause only did not run afoul of the separation of powers clause in the Constitution. Conversely, the Supreme Court will need to determine whether the Supreme Court opinion in Seila Law, LLC V. Consumer Financial Protection Bureau should apply to these two new cases. In Seila Law, the Supreme Court held on Constitutional grounds, that the President could fire without good cause the sole director of the CFPB even though the Dodd-Frank Act allowed the President to fire the sole director of the CFPB for good cause only. Until this gets resolved, the FTC will be governed only by two Republican commissioners who will constitute a quorum for purposes of conducting official business. Professor Calkins explains how a Supreme Court ruling in these two new cases upholding Trump's firing of the Democratic members of the agencies could enable the President to fire without good cause members of other multiple-member agencies, like the Federal Reserve Board. We then discuss the status of the following four final controversial FTC rule, some of which were challenged in court: the CARS Rule, the Click-to-Cancel Rule, the Junk Fee Rule, and the Non-Compete Rule. We also discuss the impact of President Trump's Executive Order requiring that all federal agencies, including so-called “independent” agencies, must obtain approval from the White House before taking any significant actions, like proposing or finalizing rules. Then, we discuss the status of enforcement investigations and litigation and whether any of them have been voluntarily dismissed with prejudice by the FTC under Trump 2.0, whether any new enforcement lawsuits been filed, and what they involve. We discuss our expectation that the FTC will be a lot less active in the consumer protection enforcement area during Trump 2.0. We then discuss the impact on staffing because of DOGE-imposed reductions-in-force. Finally, we touch upon the status of pending antitrust enforcement lawsuits. Alan Kaplinsky, former practice group leader for 25 years of the Consumer Financial Services Group and now Senior Counsel, hosts the discussion.

How can sociology reclaim its commitment to rigorous inquiry and viewpoint diversity? Today, John Tomasi sits with Jukka Savolainen, Ph.D., Sociology professor at Wayne State University in Detroit, Michigan, and the moderator of the Heterodox Academy's Sociology community. They discuss the discipline's current challenges, including ideological bias and lack of viewpoint diversity, and explore potential paths toward reform.    Jukka shares his journey into sociology and his decision to leave Finland to pursue a PhD in the United States due to concerns about postmodernist influences in Finnish sociology. He addresses the core aims of sociology, its present state of fragmentation, and the impact of ideological bias on research and discourse. Jukka highlights the importance of empirical evidence and viewpoint diversity while pointing out taboos and restrictions on certain topics within the field.The conversation also examines the role of external interventions, using the example of the Danish government's restructuring of the sociology department at Copenhagen University in the 1980s, and the more recent actions by the state of Florida. In This Episode:

Chris Holman welcomes Ann Marie Creed, Newly named president of University of Michigan Health-Sparrow Lansing, Lansing, MI. Welcome Ann, can you share your career background? We understand you start this new role May 19th? Your roles in healthcare have prepared you well for this new position? What drew you to UMH Sparrow as they underwent their search? Are there any committees or boards you will keep ties with now in this new role? Experienced health care leader Ann Marie Creed named president of University of Michigan Health-Sparrow Lansing LANSING, Mich. – Ann Marie Creed, MHSA, BA, who has extensive experience in health care leadership roles, has been named president of University of Michigan Health-Sparrow Lansing. She will begin her new job on May 19. Creed has been a vice president of Henry Ford Health System in Detroit since 2012, overseeing surgical services, operations and currently as leader of system capacity command and patient logistics. In the latter role, she oversees all admissions, transfers, bed management and much more. She also served as interim president of Henry Ford Hospital in Detroit, as vice president of Henry Ford's Wyandotte Hospital and in administrative roles with the Henry Ford Medical Group and the Wayne State Health Physician Group. Creed is also skilled in the integration of health systems and has been working on bringing Ascension hospitals' into the Henry Ford Health system. “We are incredibly pleased to have someone of Ann Marie's stature and experience join our team,” said Margaret Dimond, Ph.D., regional president, University of Michigan Health. “I worked alongside her during my time at Henry Ford Health System and have been so impressed by her knowledge and ability to execute innovative programs and initiatives. She is an exceptional leader with solid operational outcomes and expertise. Ann Marie will be a great addition to our team.” Creed's accomplishments at Henry Ford include overseeing creation of the system's virtual intensive care unit, nursing and sitter programs; consolidation of beds and transfers across the system; serving as operations lead during the pandemic; increasing surgical volume; and improving the nursing turnover rate. Creed succeeds interim president Christopher Palazzolo, who has served in that role since January and came to UM Health-Sparrow Lansing on a temporary basis as we began a nationwide search for a permanent president. Creed was selected by a search committee representing board, physician and nursing leadership and an extensive interview process that included input from team members across the organization. Creed has deep Michigan roots and received her Master of Science in Healthcare Administration from Central Michigan University and her Bachelor of Arts in Biology from Wayne State University. She is a fellow of the American College of Healthcare Executives (FACHE); is board certified as a medical practice executive from the American College of Medical Practice Executives; and is a certified green belt in Lean Six Sigma. She has served on committees of the Henry Ford Medical Group Board of Governors and the Southern Wayne County Regional Chamber. » Visit MBN website: www.michiganbusinessnetwork.com/ » Watch MBN's YouTube: www.youtube.com/@MichiganbusinessnetworkMBN » Like MBN: www.facebook.com/mibiznetwork » Follow MBN: twitter.com/MIBizNetwork/ » MBN Instagram: www.instagram.com/mibiznetwork/

  This episode features my recent speaking appearance at Wayne State University. Deep appreciation for to Professor Khari Brown as well as the Wayne State Sociology, African-American Studies, and History departments---and to Wiley Michelle Boley for filming and editing! To get access to the complete archive of the best historical research on deep political events and the tripartite state, subscribe to the American Exception podcast on Patreon at https://patreon.com/americanexception Special thanks to: Dana Chavarria, production Casey Moore, graphics Michelle Boley, animated intro Mock Orange, music

Discover how the Printed Circuit Engineering Association (PCEA) is revolutionizing electronics education through innovative training programs and university partnerships. In this episode of the OnTrack Podcast, Host Zach Peterson interviews PCEA President Mike Buetow shares insights on their mission to bridge the skills gap in PCB design, their partnership with Wayne State University, and the launch of the new PCB Detroit show.    Learn about PCEA's certified training curriculum, their vision for AI in PCB design, and how they're preparing the next generation of designers. This enlightening conversation reveals how PCEA is making PCB design knowledge more accessible through chapter-based local communities, professional certifications, and university collaborations. Mike also discusses the challenges of integrating AI into the design process and shares his perspective on the future of PCB design tools and education.  

This is the Catch Up on 3 Things by The Indian Express and I am Ichha SharmaToday is the 17th of April and here are today's headlinesThe Supreme Court declined to stay changes to the Waqf law after the Centre assured no recruitment would occur in Waqf boards and councils, and that Waqf properties would not be denotified until the next hearing. A three-judge bench led by Chief Justice Sanjiv Khanna took note of the Centre's statement. Solicitor General Tushar Mehta assured that a short response would be filed within seven days, and after a brief hearing, the bench set the next date for further proceedings.The Supreme Court will examine if a Muslim individual can choose the Indian Succession Act, 1925, over Shariat law for inheritance matters. Chief Justice Sanjiv Khanna and Justice Sanjay Kumar tagged the petition by Naushad K K, a Kerala lawyer, with a case filed by ex-Muslim Safiya PM. Safiya seeks a declaration that Muslims who renounce their faith should be governed by the Indian Succession Act instead of Muslim personal law.In response to Pakistan Army Chief General Asim Munir's claim that Kashmir is Pakistan's "jugular vein," India stated the only link is Pakistan's illegal occupation of part of Kashmir, which must end. Ministry of External Affairs Spokesperson Randhir Jaiswal rejected the remark, emphasizing that Kashmir is a union territory of India. Munir had reiterated Pakistan's stance on Kashmir and defended the two-nation theory, asserting Pakistan's ongoing claim over the region.Chinmay Deore, a 21-year-old computer science student at Wayne State University, faces deportation after US immigration authorities terminated his F-1 student visa. Deore and three other international students filed a lawsuit against the Department of Homeland Security, claiming their visa terminations were unlawful. Represented by the ACLU of Michigan, they allege they were not notified in advance about the revocation, which jeopardized their education, research, and career prospects, as detailed in their complaint.Chinese leader Xi Jinping urged Cambodia to resist protectionism as he concluded a three-nation tour of Southeast Asia. With US tariffs impacting both countries' economies, Cambodia, a major exporter to the US, faces high tariffs on its goods. Xi's comments, published in Cambodian media, stressed the importance of opposing “hegemonism” and “protectionism.” He had delivered similar messages earlier during his visits to Vietnam and Malaysia, emphasizing cooperation amidst global trade challenges.

Originally uploaded March 11th, re-edited April 4th. Chris Holman welcomes back the Honorable Sandy K. Baruah, president and chief executive officer of the Detroit Regional Chamber. Welcome back Sandy, we value our periodic discussions for you, one last look at 2024 what was its big highlight? You recently hosted your Detroit Policy Conference, can you review what came out of it? How has the Chamber been dealing with the business issues like ESTA, Corporate Transparency and other talent/human resource topics? Anything we can share with the business community about the Mackinac Policy Conference in just under 3 months from now? Thursday, Jan. 23, the Detroit Policy Conference: Driving the Innovation Economy focused on how to capitalize on recent momentum to secure our competitive position as the world innovates and develops new technologies with increasing speed. The Conference feature keynote addresses from Song Foundation's Dug Song, Oakland County Executive David Coulter, and the City of Detroit‘s Mayor Mike Duggan. It will also include Power Perspectives from leaders like the Detroit Economic Growth Corp.'s Kevin Johnson and JustAir's Darren Riley; panels with business leaders like Assembly Ventures' Jessica Robinson and education leaders like Wayne State University's Dr. Kimberly Andrews Espy; conversations with innovators like Michigan Central's Mary Culler and Josh Sirefman and Union Heritage's Nia Batts; and a reception featuring the Detroit City Council, including its President Mary Sheffield, President Pro Tem James Tate, Member Scott Benson, Member Fred Durhal III, and Member At-Large Coleman A. Young II. » Visit MBN website: www.michiganbusinessnetwork.com/ » Watch MBN's YouTube: www.youtube.com/@MichiganbusinessnetworkMBN » Like MBN: www.facebook.com/mibiznetwork » Follow MBN: twitter.com/MIBizNetwork/ » MBN Instagram: www.instagram.com/mibiznetwork/

This week, Donna and Orlando sat down with Saunteel Jenkins to discuss her vision for Detroit's future. This episode is the second in a series of interviews with candidates in the race for Detroit's 76th mayor.Saunteel Jenkins is a lifelong Detroiter, former Detroit City Council President, gun violence prevention advocate, and former CEO of The Heat and Warmth Fund (THAW), where she kept families healthy, safe, and warm.  Saunteel worked as a social worker, director of the residential treatment center at the Mariners Inn homeless shelter for men in Detroit, national business development director for a private education company that provides services to low-income children in at-risk school districts, and at one time ran her own dessert catering company, Petite Sweets.She is a proud graduate of Cass Technical High School and Wayne State University, where she earned both her Bachelor's and Master's degrees in Social Work.To learn more about Saunteel Jenkins and her six priorities for Detroit, click here.Support the showFollow us on Instagram, Facebook and Twitter.

In this episode we speak with Dr. Tamara Hew-Butler about the dangers of overhydration. Dr. Hew-Butler is a podiatric physician and associate professor of Exercise and Sports Science and Physiology at Wayne State University in Detroit, Michigan. She obtained her Bachelor of Science in Kinesiology at the University of California at Los Angeles, her Doctor of Podiatric Medicine at Temple University in Philadelphia, PA; and her Philosophy Doctor at the University of Cape Town, South Africa. Dr Hew-Butler is a Fellow of the American College of Sports Medicine and specializes in both sports medicine and exercise physiology. Her expertise is in exercise-associated hyponatremia, salt and water balance, and sports performance. She has published over 80 scientific articles and her work has been highlighted on radio shows, television, podcasts and newspapers. Learning Points: • Why is proper hydration important for our health? • What is hyponatremia and how can overhydrating lead to it? • What are some signs of overhydration? Social Media https://x.com/hyponaqueen

Segment 1 with Michael E. Gerber starts at 0.00Inc. Magazine calls him “the World's #1 Small Business Guru” — the entrepreneurial and small business thought leader who has impacted the lives of millions of small business owners and hundreds of thousands of companies worldwide for over 40 years.Michael E. Gerber is a celebrated entrepreneur, author, and business coach renowned for his groundbreaking book, "The E Myth: Why Most Businesses Don't Work and What to Do About It." With a career spanning several decades, he has transformed the way small businesses operate by emphasizing the importance of effective systems and strategic planning. Gerber's philosophy encourages entrepreneurs to work on their business rather than merely in it, fostering sustainable growth and innovation.  Segment 2 with Allen Batteau starts at 18:49.Why are we tie our self worth and identity to tech devices? Why do advances in tech many times disappoint us? Allen Batteau is a cultural anthropologist, professor at Wayne State University's Department of Anthropology, and former director of the University's Institute for Information Technology and Culture. He is the author of "Tools, Totems, and Totalities"Become a supporter of this podcast: https://www.spreaker.com/podcast/the-small-business-radio-show--3306444/support.

Dr. Saima Khan is a physician with over 27 years of experience and a deeply personal story of resilience and transformation. Diagnosed with narcolepsy in 2016 after stepping away from medicine due to chronic fatigue and excessive sleepiness, she found herself navigating the healthcare system not as a doctor but as a patient. When conventional treatments failed, she took her health into her own hands, uncovering and addressing multiple causes of brain inflammation including mold illness, Lyme disease and coinfections, chronic SIBO, mast cell activation, autoimmunity and much more. Dr. Saima holds a Doctor of Medicine from Aga Khan University, known as the "Harvard of Pakistan." She completed her Pediatric Residency at Children's Hospital of Michigan, and fellowship in Medical Toxicology at Wayne State University. She is board-certified in Pediatrics and certified in Functional Medicine from the Institute for Functional Medicine. She also has advanced training in chronic illnesses like Lyme and coinfections, and mold. As the founder of Rebalance Family Health, a virtual practice based in Florida, Dr. Saima specializes in helping adults and children with complex illnesses with a focus on lyme and coinfections, mold illness, autoimmunity and inflammatory brain disorders. Her mission is to alleviate suffering by uncovering root causes, connecting the dots, and empowering patients to live vibrant, healthy lives. Some of the topics we discussed were: How to identify mold illness in the body What people do to fix their environment if they have mold illness What to do to identify the issue in the environment that is causing the illness Where to find an environmental inspector to evaluate a building for environmental illnessWhen it is safe to live somewhere after a mold infestation The difference in the spectrum of sensitivity to mold exposure How to assess if a new environment will be safe for those sensitive to mold illness when house hunting The important role functional and integrative medicine can play in helping people with long COVIDDr. Khan's practitioner based experience of the connection between COVID and mold exposure How mold illness dysregulates the immune system and can impact long COVID symptoms 3 pieces of advice for physicians who are interested in learning and starting a functional and integrative medicine practice Where physicians can start learning more about functional and integrative medicine How functional medicine can help physicians feeling limited by conventional medicine and wanting to do more to help patients with chronic illnesses Where to find a mentor for your area of interest in the functional and integrative medicine space And more! Learn more about me or schedule a FREE coaching call:https://www.joyfulsuccessliving.com/  Join the Voices of Women Physicians Facebook Group:https://www.facebook.com/groups/190596326343825/   Connect with Dr. Khan: Website:www.rebalancefamilyhealth.com Instagram:@drsaimakhanmd 

James B. LaValle, B.S.Pharm, CCN, MT, DHM, DHPh is an internationally recognized clinical pharmacist, author, and board-certified clinical nutritionist, with over 40 years of clinical experience in natural products, lifestyle, drug/nutrient depletion, compounding pharmacy and peptides. He has served thousands of clients, using a metabolic model for health, at his facilities in Orange County, CA, Austin, TX and formerly at LaValle Metabolic Institute, in Cincinnati Ohio. He is the founder of Metabolic Code Enterprises, (www.metaboliccode.com) that pinpoints the metabolic roadblocks to health using a symptom survey, lab markers, biometrics, and wearable data. He taught for 18 years as an appointed adjunct faculty member at the University of Cincinnati College of Pharmacy served as faculty at the College of Medicine at U.C. He is Adjunct Faculty for the Masters of Integrative Medicine program at the George Washington School of Medicine and Health Sciences. Dr. Swidan is President and CEO of NeuroPharm and Former CEO of Pharmacy Solutions in Ann Arbor, MI and Adjunct Associate Professor of Clinical Research and Leadership at George Washington University School of Medicine and Health Sciences, and Adjunct Clinical Associate Professor of Pharmacy at Wayne State University. She received her Doctor of Pharmacy degree and completed a 3-year research Fellowship in Bio-Pharmaceutics and Gastroenterology at the University of Michigan. Following her fellowship, she was Director of Pharmacy at Chelsea Community Hospital and the clinical pharmacist for the inpatient head and chronic pain service. Dr. Swidan is board certified and an advanced fellow in anti-aging and regenerative medicine. She is an internationally renowned speaker in the areas of pain management, headaches, and HRT. She has authored several book chapters, articles, and patient education material in head and general pain management and personalized medicine.

Dr. Saima Khan is a physician with over 27 years of experience and a deeply personal story of resilience and transformation. Diagnosed with narcolepsy in 2016 after stepping away from medicine due to chronic fatigue and excessive sleepiness, she found herself navigating the healthcare system not as a doctor but as a patient. When conventional treatments failed, she took her health into her own hands, uncovering and addressing multiple causes of brain inflammation including mold illness, Lyme disease and coinfections, chronic SIBO, mast cell activation, autoimmunity and much more. Dr. Saima holds a Doctor of Medicine from Aga Khan University, known as the "Harvard of Pakistan." She completed her Pediatric Residency at Children's Hospital of Michigan, and fellowship in Medical Toxicology at Wayne State University. She is board-certified in Pediatrics and certified in Functional Medicine from the Institute for Functional Medicine. She also has advanced training in chronic illnesses like Lyme and coinfections, and mold. As the founder of Rebalance Family Health, a virtual practice based in Florida, Dr. Saima specializes in helping adults and children with complex illnesses with a focus on lyme and coinfections, mold illness, autoimmunity and inflammatory brain disorders. Her mission is to alleviate suffering by uncovering root causes, connecting the dots, and empowering patients to live vibrant, healthy lives. Some of the topics we discussed were: Being a mold-literate and lyme-literate physician Treating mold related illness and Lyme and coninfections from an integrative medicine perspective  How integrative medicine is useful for identifying root causes in people who are chronically sick and cannot seem to find answers Dr. Khan's path to completing her training in functional medicine What functional medicine teaches us and why these concepts are so important to cover in medical school curriculums How the process of treating patients on the drivers of illness differs from the conventional model of diagnosis What the mental, spiritual, and emotional piece of one's life manifests as in their health Functional medicine's role in evaluating the different aspects of a patient who is suffering and is not well When Dr. Khan realized she had mold exposure and what she did for treatment How Dr. Khan learned more about pediatric conditions for starting her functional and integrative medicine practice Where Dr. Khan received training for inflammatory brain conditions and how it linked to narcolepsy The pieces of Dr. Khan's journey to recovery and education in functional and integrative medicine How Dr. Khan expanded to treating adults in addition to children The high need for more physicians trained in treating mold illness and Lyme and confections to meet the high demand of patients who are very suffering and cannot find help How Dr. Khan easily arranges for lab work and imaging to be done for her virtual practice The role of functional medicine in more simple treatments for ADHD that do not require medication And more!Learn more about me or schedule a FREE coaching call:https://www.joyfulsuccessliving.com/ Join the Voices of Women Physicians Facebook Group:https://www.facebook.com/groups/190596326343825/  Connect with Dr. Khan: Website:www.rebalancefamilyhealth.com Instagram:@drsaimakhanmd 

[RE-UPLOAD FROM MAR. 10, 2021]On this episode, Jen and Ariana chatted with Dr. Julie Lesnik, an associate professor of Anthropology at Wayne State University in Detroit. She studies the evolution of humans eating insects and has even wrote a book on it called Edible Insects and Human Evolution. We chatted about how humans evolved to eat insects, her time studying chimpanzees in Africa, and gives some advice to graduate students within STEM.Watch this interview on YouTube here!You can follow Bug Talk on Instagram and Twitter @bugtalkpodcast, and YouTube @bugtalk6645

Using innovation to attract urban talent to sustainable cities including: NYC, LA County, and Detroit (plus a touch of London and Italy)!CIV:LAB was born out of a need for more coordination and collaboration between the various stakeholders that work to make cities more sustainable. We sit down with Founder and Executive Director, Simon Sylvester-Chaudhuri, and Chief of Staff, Allison Lucas, to learn more about CIV:LAB's mission and vision.CIV:LAB's work in Michigan began with working with Wayne State University, TechTown and Next Energy, helping secure a $1m grant from the Economic Development Administration. They continue to work closely with each of them, the University of Michigan, City of Detroit and a number of local urban innovators. 

Dr. Saima Khan is a physician with over 27 years of experience and a deeply personal story of resilience and transformation. Diagnosed with narcolepsy in 2016 after stepping away from medicine due to chronic fatigue and excessive sleepiness, she found herself navigating the healthcare system not as a doctor but as a patient. When conventional treatments failed, she took her health into her own hands, uncovering and addressing multiple causes of brain inflammation including mold illness, Lyme disease and coinfections, chronic SIBO, mast cell activation, autoimmunity and much more. Dr. Saima holds a Doctor of Medicine from Aga Khan University, known as the "Harvard of Pakistan." She completed her Pediatric Residency at Children's Hospital of Michigan, and fellowship in Medical Toxicology at Wayne State University. She is board-certified in Pediatrics and certified in Functional Medicine from the Institute for Functional Medicine. She also has advanced training in chronic illnesses like Lyme and coinfections, and mold. As the founder of Rebalance Family Health, a virtual practice based in Florida, Dr. Saima specializes in helping adults and children with complex illnesses with a focus on lyme and coinfections, mold illness, autoimmunity and inflammatory brain disorders. Her mission is to alleviate suffering by uncovering root causes, connecting the dots, and empowering patients to live vibrant, healthy lives. Some of the topics we discussed were: Dr. Khan's background in toxicology Where Dr. Khan found her information on toxins Dr. Khan's next steps to address the root cause of her narcolepsy Mold and microtoxin illness How Dr. Khan's narcolepsy symptoms have vastly improved What the last missing piece was for Dr. Kahn in recovering from her narcolepsy And more!Learn more about me or schedule a FREE coaching call:https://www.joyfulsuccessliving.com/ Join the Voices of Women Physicians Facebook Group: https://www.facebook.com/groups/190596326343825/  Connect with Dr. Khan: Website:www.rebalancefamilyhealth.com Instagram:@drsaimakhanmd 

In this episode of HR Like a Boss, Amy Bouque, Chief People Officer at Kelly®, discusses the evolution of HR from a compliance-driven function to a strategic, people-centered force for business success. Amy shares her career journey, the risks she took along the way, and how authenticity in leadership can shape a thriving workplace culture. She dives into HR transformation, the critical role of people managers, and how engagement and trust can make or break an organization. Tune in to hear insights on purpose-driven leadership and the power of putting people at the center of business.ABOUT AMY BOUQUEAmy Bouque has a passion for empowering people to thrive at work and in life. As chief human resources officer for Kelly®, a global leader in providing strategic workforce solutions and connecting talented people to great companies, she does exactly that. Amy leads the human resources practices for the more than 7,000 internal full-time Kelly employees around the world. She views their dedication to connecting people of all backgrounds with work that enriches their lives as a truly noble cause. Describing herself as an ally to all people, Amy strives to accelerate the success of Kelly through transformative people initiatives that help employees find their purpose and achieve their full potential through meaningful work. Citing empowerment, inclusion and compassion as guiding principles, Amy says it is a privilege to be a people leader at a talent-focused organization that embraces the full humanity of all workers and supports all workstyles. Amy extends her commitment to enabling human centered success through her roles as an HR advisor for Semper Virens Venture Capital and beyond the world at work. She's equally committed to lifting her community, being a founding member and former board president of Impact100 Metro Detroit, and a current member of the board of the Ruth Ellis Center. Amy holds degrees from both Michigan State University and Wayne State University. With both kids off to college, Amy enjoys her role as a bird launcher (empty nester). In her newly found spare time, she enjoys reading, hiking, kayaking and sitting at a bonfire with a glass of red wine.

Dr. Saima Khan is a physician with over 27 years of experience and a deeply personal story of resilience and transformation. Diagnosed with narcolepsy in 2016 after stepping away from medicine due to chronic fatigue and excessive sleepiness, she found herself navigating the healthcare system not as a doctor but as a patient. When conventional treatments failed, she took her health into her own hands, uncovering and addressing multiple causes of brain inflammation including mold illness, Lyme disease and coinfections, chronic SIBO, mast cell activation, autoimmunity and much more.Dr. Saima holds a Doctor of Medicine from Aga Khan University, known as the "Harvard of Pakistan." She completed her Pediatric Residency at Children's Hospital of Michigan, and fellowship in Medical Toxicology at Wayne State University. She is board-certified in Pediatrics and certified in Functional Medicine from the Institute for Functional Medicine. She also has advanced training in chronic illnesses like Lyme and coinfections, and mold.As the founder of Rebalance Family Health, a virtual practice based in Florida, Dr. Saima specializes in helping adults and children with complex illnesses with a focus on lyme and coinfections, mold illness, autoimmunity and inflammatory brain disorders. Her mission is to alleviate suffering by uncovering root causes, connecting the dots, and empowering patients to live vibrant, healthy lives.Some of the topics we discussed were:How Dr. Khan's journey into functional and integrative medicine began from her narcolepsyDr. Khan's first steps for finding a solution to her narcolepsy Why stimulants and conventional medicine designed to keep you awake can only help so much with narcolepsyNarcolepsy being an autoimmune condition How reducing inflammation through Dr. Khan's diet reduced her narcolepsy symptomsWhat intervention Dr. Khan says helped her the most if she had to choose only oneWhy detoxifying the body and environment is like fixing a plumbing problemHow detoxifying reduces narcolepsy symptomsAnd more!Learn more about me or schedule a FREE coaching call:https://www.joyfulsuccessliving.com/Join the Voices of Women Physicians Facebook Group:https://www.facebook.com/groups/190596326343825/Connect with Dr. Khan:Website:www.rebalancefamilyhealth.comInstagram:@drsaimakhanmd

1. Five signs that you might have a boundary problem. 2. Why each of us should stop pretending we're not a needy person. 3. How to stop arguing like a lawyer – and start communicating like a kindergartener – to get what you need.  4. How to know when to end an argument, how to exit a friendship, and how to respond to passive aggressiveness.  About Nedra: Nedra Glover Tawwab, MSW, LCSW, is a New York Times best-selling author, licensed therapist, and sought-after relationship expert. She has practiced relationship therapy for 15 years and is the founder and owner of the group therapy practice, Kaleidoscope Counseling. Every day she helps people create healthy relationships by teaching them how to implement boundaries. Her philosophy is that a lack of boundaries and assertiveness underlie most relationship issues, and her gift is helping people create healthy relationships with themselves and others. Nedra earned her undergraduate and graduate degrees from Wayne State University in Detroit, MI. She has additional certifications in working with families and couples and in perinatal mood and anxiety disorders, plus advanced training for counseling adults who've experienced childhood emotional neglect. Nedra has appeared as an expert on Red Table Talk, The Breakfast Club, Good Morning America, and CBS Morning Show to name a few. Her work has been highlighted in The New York Times, The Guardian, and Vice and has appeared on numerous podcasts, including Good Life Project, Sofia with an F, and Therapy For Black Girls. She runs a popular Instagram account where she shares practices, tools, and reflections for mental health and hosts weekly Q&As.   TW: @NedraTawwab IG: @nedratawwab To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices